CUSIP: 33938J106
Q3 2019 13F Holders as of 30 Sep 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
34,445,576
-
Share change
-
+1,951,837
-
Total reported value
-
$472,198,593
-
Put/Call ratio
-
36%
-
Price per share
-
$13.70
-
Number of holders
-
123
-
Value change
-
+$27,578,890
-
Number of buys
-
58
-
Number of sells
-
45
Quarterly Holders Quick Answers
What is CUSIP 33938J106?
CUSIP 33938J106 identifies FLXN - FLEXION THERAPEUTICS INC - COM in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2019
-
Previous quarter:
Q2 2019
Recent filing periods for CUSIP 33938J106:
Institutional Holders of FLEXION THERAPEUTICS INC - COM (FLXN) as of Q3 2019
As of 30 Sep 2019,
FLEXION THERAPEUTICS INC - COM (FLXN) was held by
123 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
34,445,576 shares.
The largest 10 holders included
MILLER VALUE PARTNERS, LLC, BlackRock Inc., Capital World Investors, WASATCH ADVISORS INC, VANGUARD GROUP INC, Bank of New York Mellon Corp, STATE STREET CORP, MORGAN STANLEY, KINGDON CAPITAL MANAGEMENT, L.L.C., and TPG Group Holdings (SBS) Advisors, Inc..
This page lists
123
institutional shareholders reporting positions in this security
for the Q3 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.